Insider Transactions in Q1 2024 at Balchem Corp (BCPC)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 08
2024
|
Michael Brent Tignor SVP & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
5,339
-21.84%
|
$838,223
$157.65 P/Share
|
|
Mar 08
2024
|
Michael Brent Tignor SVP & Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,200
+23.45%
|
$357,000
$85.4 P/Share
|
|
Mar 04
2024
|
Matthew David Wineinger |
SELL
Open market or private sale
|
Direct |
1,333
-17.79%
|
$207,948
$156.89 P/Share
|
|
Feb 26
2024
|
William A. Backus VP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
7,000
-21.15%
|
$1,085,000
$155.38 P/Share
|
|
Feb 23
2024
|
William A. Backus VP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
9,180
-23.22%
|
$1,432,080
$156.55 P/Share
|
|
Feb 23
2024
|
William A. Backus VP & Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,180
+18.65%
|
$725,220
$79.49 P/Share
|
|
Feb 22
2024
|
Theodore L Harris Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
34,350
-12.91%
|
$5,289,900
$154.49 P/Share
|
|
Feb 22
2024
|
Theodore L Harris Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
34,350
+15.52%
|
$1,957,950
$57.86 P/Share
|
|
Feb 21
2024
|
William A. Backus VP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
15,000
-18.51%
|
$2,310,000
$154.64 P/Share
|
|
Feb 21
2024
|
William A. Backus VP & Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+34.95%
|
$900,000
$60.85 P/Share
|
|
Feb 21
2024
|
Theodore L Harris Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
29,679
-8.54%
|
$4,570,566
$154.37 P/Share
|
|
Feb 21
2024
|
Michael Robert Sestrick SVP & Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
11,100
-62.23%
|
$1,698,300
$153.21 P/Share
|
|
Feb 21
2024
|
Michael Robert Sestrick SVP & Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,100
+21.29%
|
$865,800
$78.52 P/Share
|
|
Feb 11
2024
|
Theodore L Harris Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,452
-3.47%
|
$500,540
$145.33 P/Share
|
|
Feb 11
2024
|
Michael Brent Tignor SVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
354
-3.62%
|
$51,330
$145.33 P/Share
|
|
Feb 11
2024
|
Carl Martin Bengtsson EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
832
-4.04%
|
$120,640
$145.33 P/Share
|
|
Feb 11
2024
|
Martin Luther Reid SVP Chief Supply Chain Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
325
-4.76%
|
$47,125
$145.33 P/Share
|
|
Feb 11
2024
|
William A. Backus VP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
751
-5.5%
|
$108,895
$145.33 P/Share
|
|
Feb 11
2024
|
Job Leonard Van Gunsteren SVP and GM, Specialty Products |
SELL
Payment of exercise price or tax liability
|
Direct |
281
-3.19%
|
$40,745
$145.33 P/Share
|
|
Feb 11
2024
|
Michael Robert Sestrick SVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
312
-4.43%
|
$45,240
$145.33 P/Share
|
|
Feb 11
2024
|
Jonathan Harrison Griffin SVP & GM, Animal Nutrition |
SELL
Payment of exercise price or tax liability
|
Direct |
220
-1.7%
|
$31,900
$145.33 P/Share
|
|
Feb 08
2024
|
Michael Robert Sestrick SVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,104
-13.54%
|
$157,872
$143.43 P/Share
|
|
Feb 08
2024
|
Michael Robert Sestrick SVP & Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,679
+14.68%
|
-
|
|
Feb 08
2024
|
Job Leonard Van Gunsteren SVP and GM, Specialty Products |
SELL
Payment of exercise price or tax liability
|
Direct |
957
-9.79%
|
$136,851
$143.43 P/Share
|
|
Feb 08
2024
|
Job Leonard Van Gunsteren SVP and GM, Specialty Products |
BUY
Grant, award, or other acquisition
|
Direct |
2,174
+10.17%
|
-
|
|
Feb 08
2024
|
Frederic Boned SVP/GM, Human Nutri. & Health |
BUY
Grant, award, or other acquisition
|
Direct |
1,380
+20.59%
|
-
|
|
Feb 08
2024
|
Monica Vicente |
BUY
Grant, award, or other acquisition
|
Direct |
540
+50.0%
|
-
|
|
Feb 08
2024
|
Olivier Rigaud |
BUY
Grant, award, or other acquisition
|
Direct |
540
+50.0%
|
-
|
|
Feb 08
2024
|
Michael Brent Tignor SVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,244
-11.29%
|
$177,892
$143.43 P/Share
|
|
Feb 08
2024
|
Michael Brent Tignor SVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,004
+12.6%
|
-
|
|
Feb 08
2024
|
Martin Luther Reid SVP Chief Supply Chain Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,688
-10.42%
|
$241,384
$143.43 P/Share
|
|
Feb 08
2024
|
Martin Luther Reid SVP Chief Supply Chain Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,113
+21.29%
|
-
|
|
Feb 08
2024
|
Hatsuki Miyata EVP, Gen. Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
1,160
+17.01%
|
-
|
|
Feb 08
2024
|
Joyce J. Lee |
BUY
Grant, award, or other acquisition
|
Direct |
540
+16.28%
|
-
|
|
Feb 08
2024
|
Daniel E Knutson |
BUY
Grant, award, or other acquisition
|
Direct |
540
+9.66%
|
-
|
|
Feb 08
2024
|
Theodore L Harris Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,768
-10.57%
|
$1,682,824
$143.43 P/Share
|
|
Feb 08
2024
|
Theodore L Harris Chairman, President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
27,289
+11.24%
|
-
|
|
Feb 08
2024
|
Jonathan Harrison Griffin SVP & GM, Animal Nutrition |
SELL
Payment of exercise price or tax liability
|
Direct |
793
-5.77%
|
$113,399
$143.43 P/Share
|
|
Feb 08
2024
|
Jonathan Harrison Griffin SVP & GM, Animal Nutrition |
BUY
Grant, award, or other acquisition
|
Direct |
3,110
+10.38%
|
-
|
|
Feb 08
2024
|
Kathleen B Fish |
BUY
Grant, award, or other acquisition
|
Direct |
540
+25.48%
|
-
|
|
Feb 08
2024
|
Carl Martin Bengtsson EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,868
-12.23%
|
$410,124
$143.43 P/Share
|
|
Feb 08
2024
|
Carl Martin Bengtsson EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,065
+13.84%
|
-
|
|
Feb 08
2024
|
David B Fischer |
BUY
Grant, award, or other acquisition
|
Direct |
540
+3.71%
|
-
|
|
Feb 08
2024
|
William A. Backus VP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,130
-7.64%
|
$161,590
$143.43 P/Share
|
|
Feb 08
2024
|
William A. Backus VP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,689
+8.42%
|
-
|
|
Feb 08
2024
|
Matthew David Wineinger |
BUY
Grant, award, or other acquisition
|
Direct |
540
+6.72%
|
-
|